Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in neonatal sepsis
NCT04474327Phase 1Completed
- Sponsor
- Mansoura University Children Hospital
- Start
- Jul 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in neonatal sepsis (2 arms), sponsored by Mansoura University Children Hospital. Primary endpoint: Change in serum tumor necrosis factor (TNF) Alpha level at 10 days. Started Jul 2020; status: completed.
02
Drugs
montelukast
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on NCT04474327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04474327.